Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 51
Filter
1.
J Am Geriatr Soc ; 48(10): 1211-5, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11037006

ABSTRACT

OBJECTIVES: To test the hypothesis that infection control practices can prevent the spread of vancomycin-resistant enterococci (VRE) to residents of a long-term care facility (LCF) from an affiliated acute care facility with a high endemic rate of colonization. DESIGN: Point prevalence study of the rate of rectal colonization. SETTING: A state-supported veterans nursing home and an acute care veterans hospital. PARTICIPANTS: Residents in a state veterans home. INTERVENTIONS: Identification of patients with rectal colonization by VRE before transfer to the state veterans home, contact isolation for colonized veterans, use of oral bacitracin to eliminate colonization. MEASUREMENTS: Rectal swab and culture for VRE, review of clinical records and recording of presumptive risk factors for VRE colonization. The risk factors were age, gender, length of stay at nursing home, treatment with vancomycin or oral antibiotics, prior hospitalization at the acute care facility during the prior year, use of indwelling urethral catheters, presence of diarrhea, and fecal or urinary incontinence. RESULTS: Sixty-nine of 200 residents were cultured in the first study (1996) and 130 of 230 residents were cultured in the second study (1998). Residents who consented to culture differed from those who did not only with regards to gender (2 vs 7, P = .012). In neither study were any residents found to be colonized with VRE who had not already been identified as positive on admission. CONCLUSIONS: Adherence to infection control practices by the patient care staff of the LTCF was associated with the absence of transmission of VRE colonization among its residents. The presence of rectal colonization with VRE in an acute care patient should not be a barrier to acceptance in a nursing home.


Subject(s)
Carrier State/prevention & control , Endemic Diseases/prevention & control , Enterococcus , Gram-Positive Bacterial Infections/prevention & control , Infection Control/methods , Rectum/microbiology , Skilled Nursing Facilities , Vancomycin Resistance , Administration, Oral , Aged , Anti-Bacterial Agents/therapeutic use , Bacitracin/therapeutic use , Carrier State/epidemiology , Carrier State/transmission , Case-Control Studies , Endemic Diseases/statistics & numerical data , Female , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/etiology , Gram-Positive Bacterial Infections/transmission , Hospitals, Veterans , Humans , Male , Patient Transfer , Prevalence , Rhode Island/epidemiology , Risk Factors , United States , United States Department of Veterans Affairs
3.
Ann Intern Med ; 119(8): 863, 1993 Oct 15.
Article in English | MEDLINE | ID: mdl-8379616
5.
Antimicrob Agents Chemother ; 31(9): 1359-64, 1987 Sep.
Article in English | MEDLINE | ID: mdl-3314697

ABSTRACT

Multiple factors may modify the pharmacokinetics of aminoglycosides and affect their nephrotoxic potential. In the present study, the influence of Escherichia coli pyelonephritis on the renal handling of [3H]tobramycin was investigated. The accumulation of [3H]tobramycin in proximal and distal tubules in both normal and infected rats was compared. Following induction of pyelonephritis, disturbed intrarenal localization of the drug was noted. Grain counts were affected in both proximal and distal tubules. Decreased labeling was observed at all time intervals in the proximal tubules. Electron microscopy showed that radioactivity was associated mostly with lysosomes in both normal and infected rats 1 and 24 h following the injection of the drug. We could detect significantly higher amounts of drug in the distal tubules of the pyelonephritic kidney than the normal levels at 10 min and 24 h postinjection. The drug did not seem to be associated with any particular organelle and was evenly distributed within the distal tubular cells. The present study shows that the transport of tobramycin within the infected nephron is disturbed. These data might shed some light on the influence of infection on the intrarenal pharmacology of aminoglycosides.


Subject(s)
Kidney Tubules, Distal/metabolism , Kidney Tubules, Proximal/metabolism , Kidney Tubules/metabolism , Pyelonephritis/metabolism , Tobramycin/metabolism , Animals , Autoradiography , Escherichia coli Infections/metabolism , Escherichia coli Infections/pathology , Female , Microscopy, Electron , Pyelonephritis/pathology , Rats
7.
Infect Immun ; 55(3): 534-40, 1987 Mar.
Article in English | MEDLINE | ID: mdl-2880806

ABSTRACT

We compared the degree to which Escherichia coli phase variants which do (T1P+ E. coli) or do not (T1P- E. coli) express type 1 pili (T1P) stimulate human polymorphonuclear leukocyte (PMN) oxidative activity. Unopsonized T1P+ E. coli stimulated the release of 0.20 to 0.24 nmol of H2O2 per 10(6) PMN per min and the consumption of 1.4 to 4.0 nmol of O2 per 10(6) PMN per min; no measurable PMN oxidative activity was stimulated by unopsonized T1P- E. coli. In the presence of serum opsonins, T1P+ E. coli stimulated the release of 1.12 to 1.16 nmol of H2O2 per 10(6) PMN per min and the consumption of 5.0 to 6.0 nmol of O2 per 10(6) PMN per min, whereas T1P- E. coli stimulated the release of 0.42 to 0.43 nmol of H2O2 per 10(6) PMN per min and the consumption of 0.6 to 2.0 nmol of O2 per 10(6) PMN per min. Although unaggregated T1P did not stimulate PMN, latex beads coated with T1P (T1P-latex) stimulated alpha-methylmannoside-inhibitable, opsonin-independent PMN oxidative activity. The activity stimulated by either T1P+ E. coli or T1P-latex was susceptible to inhibition by cytochalasin B. Latex particles coated with bovine serum albumin or mannose-resistant pili did not stimulate PMN. These data indicate that T1P+ E. coli stimulate PMN oxidative metabolism more effectively than do T1P- E. coli and that a similar PMN oxidative response follows cellular stimulation by either unopsonized T1P+ or opsonized T1P- E. coli. Furthermore, T1P-latex faithfully mimics the ability of T1P+ E. coli to stimulate PMN oxidative metabolism. Such particles may be useful in further analyses of cellular responses to T1P+ E. coli.


Subject(s)
Escherichia coli/physiology , Fimbriae, Bacterial/physiology , Neutrophils/metabolism , Oxygen Consumption , Concanavalin A/pharmacology , Cytochalasin B/pharmacology , Humans , Hydrogen Peroxide/biosynthesis , Latex/pharmacology , Neutrophils/drug effects , Opsonin Proteins/immunology , Polymyxin B/pharmacology
8.
J Antimicrob Chemother ; 19(2): 239-48, 1987 Feb.
Article in English | MEDLINE | ID: mdl-3553135

ABSTRACT

One hundred and thirty-five patients with bacterial pneumonia who had risk factors (alcoholism, chronic obstructive pulmonary disease, corticosteroid therapy diabetes mellitus, advanced age, solid tumours) were randomly allocated in a double-blind fashion to receive either ceftizoxime (2-4 g every 8 h), cefotaxime (1-2 g every 4 h), or latamoxef (2-4 g every 8 h). Of the 84 patients evaluable for efficacy, clinical cure was achieved in 91%, 85%, and 89% of ceftizoxime- (20/22), cefotaxime-(23/27), and latamoxef-treated (31/35) patients, respectively. Adverse reactions occurred in one of 45 ceftizoxime-treated patients, one of 43 cefotaxime-treated patients, and seven of 47 latamoxef-treated patients. Abnormal laboratory values during therapy were seen in 50% of latamoxef-treated and 43% of cefotaxime-treated patients and in 29% of ceftizoxime-treated patients. Hypoprothrombinaemia occurred in five latamoxef-treated patients and one of these patients experienced an episode of haematemesis. In this study, ceftizoxime, cefotaxime, and latamoxef were similarly effective; however, the incidence of side effects was most frequent with latamoxef.


Subject(s)
Bacterial Infections/drug therapy , Cefotaxime/analogs & derivatives , Cefotaxime/therapeutic use , Moxalactam/therapeutic use , Pneumonia/drug therapy , Aged , Aged, 80 and over , Bacterial Infections/complications , Cefotaxime/adverse effects , Ceftizoxime , Clinical Trials as Topic , Double-Blind Method , Female , Humans , Male , Middle Aged , Moxalactam/adverse effects , Pneumonia/complications , Random Allocation , Risk
9.
Arch Intern Med ; 147(2): 286-8, 1987 Feb.
Article in English | MEDLINE | ID: mdl-3813746

ABSTRACT

Results of urine cultures from 26 male nursing home patients wearing external catheters, collected by a simple standardized technique, were compared with culture results from the same patients obtained by sterile in-and-out catheterization. The culture results were the same in 22 (85%) of the matched specimens, and specimens collected by the standardized technique were 100% sensitive and 94% specific in detecting significant growth of pathogenic organisms. In contrast, 13 (57%) of 23 specimens collected from patients with external catheters by the nursing home staff using their routine technique yielded three or more organisms and were considered contaminated. These results suggest that it is possible to obtain a urine specimen that reflects bladder urine in the vast majority of patients with external catheters, and thus potentially avoid the need for in-and-out catheterization when diagnosing and planning treatment for urinary tract infections in this population.


Subject(s)
Specimen Handling/methods , Urinary Catheterization , Urine/microbiology , Aged , Humans , Male , Nursing Homes , Urinary Incontinence/therapy
11.
Infect Immun ; 54(2): 549-54, 1986 Nov.
Article in English | MEDLINE | ID: mdl-2876964

ABSTRACT

To determine whether expression of type 1 pili varies during the course of Escherichia coli infection in vivo, mice were injected intraperitoneally with 5 X 10(7) CFU of piliated or nonpiliated phase variants per ml, and the degree of piliation was measured in peritoneal exudate by an enzyme-linked immunosorbent assay inhibition method. In the animals challenged with the piliated bacteria, the numbers of organisms increased a log over 9 h and the amount of pilus antigen decreased from 3 to 0.075 micrograms/10 bacteria. After a 4-h delay, nonpiliated bacteria also increased by one log over 9 h; however, the amount of piliation remained virtually undetectable. Piliated E. coli were more virulent than nonpiliated variants in this model (50% lethal dose of 7.5 X 10(6) versus 3 X 10(7), respectively). The difference was significantly reduced by prior passive immunization with rabbit serum containing high titers of antipili antibody. Piliated bacteria adhered in significantly greater numbers to isolated mouse peritoneal membranes than did nonpiliated variants (15,400 +/- 2,700 versus 1,300 +/- 700 bacteria/mm2, respectively; P = 0.05). Adherence was inhibited by the presence of 0.1 M alpha methyl mannose (1,500 +/- 1,800 bacteria/mm2, P = 0.01). These results confirm the results of previous qualitative studies showing that phase variation of type 1 pili occurs in vivo and suggest that these pili may confer an initial advantage for growth of E. coli in the peritoneal cavity, presumably by fostering colonization of the peritoneal serosal surface.


Subject(s)
Escherichia coli Infections/microbiology , Escherichia coli/ultrastructure , Fimbriae, Bacterial/physiology , Peritonitis/microbiology , Animals , Cell Fractionation/methods , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Escherichia coli/isolation & purification , Fimbriae, Bacterial/ultrastructure , Humans , Immune Sera , Mice , Microscopy, Electron , Urinary Tract Infections/microbiology
13.
Infect Immun ; 52(2): 579-85, 1986 May.
Article in English | MEDLINE | ID: mdl-3699896

ABSTRACT

The binding of immunoglobulin G present in syphilitic immune rabbit serum, syphilitic human serum, and rabbit antiserum to purified recombinant Treponema pallidum antigen 4D by T. pallidum, Nichols strain, was studied by immunoelectron microscopy. Treponemes were incubated with antiserum under the conditions of the T. pallidum immobilization test, in which T. pallidum-specific antibody renders the organism nonmotile and avirulent only in the presence of complement after a 16-h incubation period in an anaerobic environment. Antibody was not demonstrable on the surface of T. pallidum incubated with nonimmune rabbit serum or normal human serum in the presence of complement. Similarly, in the absence of complement, little or no antibody was found on the treponemal surface after incubation with syphilitic immune rabbit serum, syphilitic human serum, or rabbit antiserum directed against the recombinant 4D antigen. The addition of complement to syphilitic immune rabbit serum, syphilitic human serum, and anti-4D antibody resulted in immobilization and the deposition of antibody on the entire surface of the immobilized organisms. These results corroborate earlier work by other investigators demonstrating the resistance of freshly isolated T. pallidum to antibody binding in a variety of serological tests. Detection of 4D antigen on the surface of immobilized T. pallidum strongly implies that the use of T. pallidum immobilization test conditions provides a means to demonstrate the association of individual surface antigens on virulent T. pallidum. The resistance of T. pallidum to antibody binding may be relevant to the pathogenesis of syphilis.


Subject(s)
Antigens, Protozoan/immunology , Recombinant Proteins/immunology , Treponema/immunology , Animals , Antibodies/immunology , Antigen-Antibody Reactions , Antigens, Protozoan/genetics , Complement System Proteins/immunology , Microscopy, Electron , Syphilis/immunology , Treponema/pathogenicity
14.
Infect Immun ; 51(1): 193-8, 1986 Jan.
Article in English | MEDLINE | ID: mdl-2867043

ABSTRACT

Human polymorphonuclear leukocytes (PMN) ingest type I (mannose sensitive) fimbriated Escherichia coli even in the absence of antibody, complement, or other serum opsonins. Our studies suggest that the Tamm-Horsfall urinary glycoprotein (THP) interferes with serum-independent ingestion. Electron micrographs showed that dissolved THP adhered to type I fimbriae and formed a pseudocapsule around bacteria bearing type I fimbriae. Phase-variant bacteria grown on blood agar neither expressed fimbriae nor bound THP. Affinity column chromatography demonstrated mannose-sensitive binding between purified type I fimbriae and purified THP. The ability of human PMN to bind and ingest type I-fimbriated E. coli was diminished if the bacteria had been coated by exposure to THP at physiologic concentrations. At 1 h, PMN were associated with an average of 2.62 uncoated bacteria, but with only 0.18 coated bacteria (P less than 0.001). alpha-Methyl mannoside blocked the observed effect of THP on binding and phagocytosis in a dose-dependent fashion: increased mannoside led to increased blocking. PMN preincubated with THP were able to bind and phagocytose normally. There did not appear to be any significant clumping of bacteria in suspension to account for these effects. Bactericidal assays with leukocytes in suspension demonstrated protection of THP-coated bacteria. At 1 h, PMN killed 42% of noncoated E. coli (a decrease of 0.24 log), but the number of THP-coated bacteria increased by 75% (an increase of 0.24 log). These observations may partially explain the virulence of E. coli in the bladder and kidney, where serum activity is low and THP is abundant.


Subject(s)
Escherichia coli/immunology , Fimbriae, Bacterial , Mucoproteins/physiology , Neutrophils/immunology , Adhesiveness , Cells, Cultured , Humans , Mannosides/pharmacology , Methylmannosides , Mucoproteins/isolation & purification , Phagocytosis , Protein Binding , Uromodulin
15.
Infection ; 11(4): 235-8, 1983.
Article in English | MEDLINE | ID: mdl-6137459

ABSTRACT

Since Duguid and Guilles first described the ability of piliated bacteria to bind to leukocytes, much has been learned about the nature of this interaction. Mannose-sensitive (MS) pili bind to specific mannose-containing receptors on the leukocyte surface. While MS pili are responsible for attachment, the relative hydrophobicity of the bacterial surface determines whether the organism is internalized. Both binding and ingestion trigger the leukocyte to respond with degranulation and enhanced oxidative activity. The response to piliated bacteria, however, is delayed as compared to bacteria opsonized with serum, which may account for the reduced bactericidal activity associated with pili-mediated phagocytosis. A number of factors appear to influence the significance of pili-mediated phagocytosis in vivo. These include natural selective pressures in the host tissue, the ability of the organism to undergo pili phase transition and the presence of serum or other host opsonic factors. Antipili antibody does not enhance leukocyte killing of MS + Escherichia coli, but does stimulate leukocyte metabolic activity. Antipili antibody may, therefore, have an adverse effect on the infectious process by promoting the extracellular release of inflammatory material from the granulocyte.


Subject(s)
Fimbriae, Bacterial/metabolism , Leukocytes/metabolism , Animals , Antibodies, Bacterial/physiology , Escherichia coli/metabolism , Fimbriae, Bacterial/immunology , Humans , Leukocytes/microbiology , Leukocytes/ultrastructure , Phagocytosis , Proteus mirabilis/metabolism , Proteus mirabilis/ultrastructure , Pyelonephritis/blood , Pyelonephritis/microbiology , Rats , Receptors, Fc
16.
J Infect Dis ; 147(5): 882-9, 1983 May.
Article in English | MEDLINE | ID: mdl-6132951

ABSTRACT

To identify mechanisms whereby antibody to mannose-sensitive pili of Escherichia coli might enhance host defenses, we evaluated the activity of antibody to pili in four antibacterial immune processes. Antiserum to pili and Fab' fragments of IgG antibody to pili inhibited the ability of homologous piliated organisms to adhere to buccal epithelial cells. However, this antiserum did not enhance intravascular clearance, complement-dependent bacteriolysis, or opsonophagocytosis. The addition of antiserum to pili to polymorphonuclear leukocytes and piliated E. coli reduced the rate of killing from 52% to 5%. The addition of complement restored the rate to 52%, but this was much less than the 99% rate achieved with polymorphonuclear leukocytes and either fresh serum or antibody to the whole bacteria. These observations suggest that the principal anti-bacterial property of antibody to mannose-sensitive pili of E. coli is inhibition of bacterial attachment. Whether the anti-opsonic effect of antibody to pili is detrimental to host defense remains to be determined.


Subject(s)
Antibodies, Bacterial/immunology , Escherichia coli/immunology , Fimbriae, Bacterial/immunology , Mannose/pharmacology , Adhesiveness , Animals , Complement System Proteins/immunology , Fimbriae, Bacterial/drug effects , Immunoglobulin Fab Fragments/immunology , Immunoglobulin G/immunology , Neutrophils/immunology , Opsonin Proteins/immunology , Phagocytosis , Rats , Rats, Inbred Strains
17.
Infect Immun ; 39(3): 1334-45, 1983 Mar.
Article in English | MEDLINE | ID: mdl-6132877

ABSTRACT

In the present study, we assayed protein iodination in human granulocytes after interaction of the cells with mannose-specific (MS) type 1 fimbriated (MS+) and nonfimbriated (MS-) phenotypes of Escherichia coli pretreated with various amounts of anti-E. coli and antifimbrial antibodies. The MS+ phenotype stimulated protein iodination in granulocytes and possessed potent MS activity as measured by yeast aggregometry. In contrast, the MS- phenotype lacked all these activities. MS+ pretreated with moderate concentrations of antibodies, however, showed up to a 15-fold increase in granulocyte stimulation as compared to granulocyte stimulation induced by the non-antibody-treated MS+ phenotype or by the antibody-treated MS- phenotype. This marked antibody-mediated increase in stimulation of granulocytes was (i) dependent on the antibody concentrations, (ii) markedly reduced by methyl-alpha-D-mannoside, (iii) caused by immunoglobulin G as well as by F(ab')2, (iv) caused only by antifimbrial antibodies, (v) associated with cross-linked fimbriae seen as "bundles" under an electron microscope, and (vi) mimicked by treating MS+ bacteria with a certain range of glutaraldehyde. The data taken together support the hypothesis that, although cross-linking of fimbriae reduced the density of functional MS fimbriae over the surface of antibody-treated bacteria and consequently reduced the ability of these organisms to agglutinate yeast cells, the resulting bundles of MS fimbriae were far more effective at stimulating granulocytes because, bound together, they were better equipped to aggregate the mannose-containing receptors on the granulocyte surface.


Subject(s)
Antibodies, Bacterial/physiology , Escherichia coli/physiology , Fimbriae, Bacterial/physiology , Granulocytes/metabolism , Antigen-Antibody Reactions , Escherichia coli/immunology , Escherichia coli/ultrastructure , Fimbriae, Bacterial/immunology , Glutaral/pharmacology , Humans , Immunoglobulin Fab Fragments/immunology , Immunoglobulin G/physiology , Mannose/pharmacology , Methylmannosides/pharmacology , Proteins/metabolism , Saccharomyces cerevisiae/physiology
18.
Scand J Infect Dis ; 15(1): 57-64, 1983.
Article in English | MEDLINE | ID: mdl-6133346

ABSTRACT

The role of pili as a bacterial virulence factor has been studied. The model used was acute ascending Escherichia coli pyelonephritis in the mouse. Three strains of E. coli were injected in lightly or more heavily piliated phases into 15 mice each. At sacrifice of 13-15 animals 2 weeks later, no significant difference in severity of pyelonephritis was found as judged by numbers of bacteria in the kidney, nor intensity or frequency of gross abscesses. 27 strains of E. coli were order ranked for severity of pyelonephritis produced and compared with intensity of piliation in vitro under conditions designed to maximize pilus formation. No significant difference was found. 15 strains derived from patients in whom infections were confined to the bladder were compared for degree of piliation with 12 strains infecting the kidney. No significant difference was found. These studies do not support a significant role for the degree of piliation as a virulence factor in pyelonephritis.


Subject(s)
Escherichia coli/pathogenicity , Fimbriae, Bacterial/physiology , Pyelonephritis/microbiology , Adhesiveness , Animals , Disease Models, Animal , Escherichia coli Infections/microbiology , Mice , Time Factors , Virulence
19.
Infect Immun ; 38(2): 542-7, 1982 Nov.
Article in English | MEDLINE | ID: mdl-6128309

ABSTRACT

Antipili antibody (APA) was quantitated by enzyme-linked immunosorbent assay in the serum, urine, and vaginal secretions of 12 women with cystitis due to Escherichia coli. Pili were purified from the strain infecting each patient. The geometric mean titers of APA in serum taken at the initial visit were: immunoglobulin G (IgG), 23.7 +/- 3.9; IgA, 4.1 +/- 4.0; and IgM, 4.4 +/- 5.7. No consistent change was observed between samples obtained at 3 and 6 weeks. APA in serum from 10 control patients was assayed against a pool of pili assembled from the 12 infecting isolates. The geometric mean titers of the control sera were: IgG, 8.4 +/- 3.2; IgA, 9.6 +/- 2.4; and IgM, 0. Antipili IgG and IgM were significantly greater in the infected than in the control sera (P less than 0.05). APA was not detected in the urine or vaginal secretions from any infected or control patient. Antigenic relationships between the 12 infecting strains were investigated by indirect immune electron microscopy. All but 1 of 12 infecting strains shared antigenic determinants. Two patients had a second E. coli infection during the study. The pili of the reinfecting isolates showed partial antigenic cross-reactivity with the pili of the initial infecting bacteria. These observations indicate that although cystitis stimulates the development of serum APAs, it fails to stimulate local APA and thus may not engender any immunological barrier to subsequent recolonization.


Subject(s)
Antibodies, Bacterial/analysis , Cystitis/immunology , Escherichia coli Infections/immunology , Escherichia coli/immunology , Fimbriae, Bacterial/immunology , Adult , Antibodies, Bacterial/urine , Cystitis/etiology , Female , Humans , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Vagina/immunology , Vagina/metabolism
20.
Rev Infect Dis ; 4 Suppl: S360-5, 1982.
Article in English | MEDLINE | ID: mdl-7178755

ABSTRACT

Third-generation cephalosporins promise to replace combinations containing aminoglycosides as safer, broad-spectrum antibiotic therapy. First, however, the possibility of nephrotoxicity as demonstrated with cephaloridine, must be excluded. For this reason, we must understand more about how cephalosporins and aminoglycosides damage the kidneys. Aminoglycosides accumulate in the renal lysosomes and may interfere with Na+-, K+-dependent adenosine triphosphatase activity. Experiments with cephaloridine and cephaloglycin, two nephrotoxic cephalosporins, indicate that they cause mitochondrial injury that leads to impaired cellular respiration. Results of experiments on the effects of treatments that combine cephalosporin with aminoglycosides or other drugs are confusing because inappropriate experimental models were used. Use of insensitive animals, administration of diuretics without prior induction of tubule damage, and insufficient dosages of drugs all cloud the interpretation of results. The standards for animal studies of cephalosporin nephrotoxicity should be revised to make them more relevant to humans.


Subject(s)
Aminoglycosides/toxicity , Anti-Bacterial Agents/toxicity , Cephalosporins/toxicity , Kidney/drug effects , Animals , Cephaloglycin/toxicity , Cephaloridine/toxicity , Diuretics/administration & dosage , Drug Interactions , Guinea Pigs , Kidney Diseases/chemically induced , Kidney Tubules/ultrastructure , Rabbits , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...